TORRENT PHARMACEUTICALS LTD. - 500420 - Corporate Action-Board approves Dividend
Dividend update02-02-2024
02-02-2024
TORRENT PHARMACEUTICALS LTD. - 500420 - Announcement under Regulation 30 (LODR)-Dividend Updates
Dividend update02-02-2024
TORRENT PHARMACEUTICALS LTD. - 500420 - Announcement under Regulation 30 (LODR)-Investor Presentation
Investor presentation02-02-2024
TORRENT PHARMACEUTICALS LTD. - 500420 - Intimation Pursuant To Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
Intimation pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 201530-01-2024
TORRENT PHARMACEUTICALS LTD. - 500420 - Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Mehta Family Trust 1 & Others & PACs30-01-2024
TORRENT PHARMACEUTICALS LTD. - 500420 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Mehta Family Trust 1 & Others & PACs30-01-2024
TORRENT PHARMACEUTICALS LTD. - 500420 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Mehta Family Trust & PACs24-01-2024
TORRENT PHARMACEUTICALS LTD. - 500420 - Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Mehta Family Trust & PACs24-01-2024